drugset / Trial / NCT07034807
YiqiJiangzhuoHuoxueTongluo Method to Delay the Occurrence of End-stage Renal Disease in Diabetic Kidney Disease--Study2
Not yet recruiting
228 enrolled
Liu Hongfang
Affiliated Hospital of Changchun University of Chinese Medicine · collabEFONG PHARMRCEUTICRL · collabFirst Affiliated Hospital, Sun Yat-Sen University · collabGuang'anmen Hospital，China Academy of Chinese Medical Sciencescancel · collabTianjin Medical University · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
Using the practical randomized controlled trial designed by Zelen, the subjects were randomly divided into the experimental group and the control group. The experimental group was given the traditional Chinese medicine prescription ' Shenzhuo Decoction ' ( composed of Astragalus membranaceus, Salvia miltiorrhiza, Leech, Raw Rhubarb, Epimedium, Motherwort ) + basic treatment ( including nutrition, lifestyle, hypoglycemic, hypotensive, lipid-lowering, control of other risk factors, etc. ), the control group was given basic treatment, a total of 1 year of drug intervention, followed up for 1 year.
Timeline
- Start
- 2025-08-01
- Primary completion
- 2028-07-31
- Completion
- 2028-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Shenzhuo Decoction | Traditional medicine (herbal / TCM) | — | — |